Literature DB >> 2420768

A monoclonal antibody against HLA-A11 and A24.

S K Foung, B Taidi, D Ness, F C Grumet.   

Abstract

A monoclonal IgG antibody was produced from a mouse immunized with an A11, A24; B27, B44 Epstein-Barr virus transformed B lymphoblastoid cell line. The antibody, A11.1M, by standard lymphocytotoxicity assay, reacts with all cells expressing HLA-A11 and -A24. Absorption studies with both A11+, A24- and A11-, A24+ platelets removed antibody reactivity against A11 and A24 lymphocytes. The shared antigenic determinant between A11 and A24, as defined by this antibody, A11.1M, represents a new "supertypic" determinant.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2420768     DOI： 10.1016/0198-8859(86)90006-6

Source DB:  PubMed          Journal:  Hum Immunol        ISSN： 0198-8859            Impact factor:   2.850


  9 in total

1.  MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.

Authors:  Martin S Staege; Steven P Lee; Teresa Frisan; Josef Mautner; Siegfried Scholz; Alexander Pajic; Alan B Rickinson; Maria G Masucci; Axel Polack; Georg W Bornkamm
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

2.  Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation.

Authors:  Judith Racape; Francine Connan; Johan Hoebeke; Jeannine Choppin; Jean-Gérard Guillet
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

3.  DNA sequence of HLA-A11: remarkable homology with HLA-A3 allows identification of residues involved in epitopes recognized by antibodies and T cells.

Authors:  E P Cowan; M L Jelachich; W E Biddison; J E Coligan
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

4.  Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein.

Authors:  Jun Liu; Peng Wu; Feng Gao; Jianxun Qi; Ai Kawana-Tachikawa; Jing Xie; Christopher J Vavricka; Aikichi Iwamoto; Taisheng Li; George F Gao
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

5.  Amyloid precursor-like protein 2 association with HLA class I molecules.

Authors:  Amit Tuli; Mahak Sharma; Xiaojian Wang; Laura C Simone; Haley L Capek; Steven Cate; William H Hildebrand; Naava Naslavsky; Steve Caplan; Joyce C Solheim
Journal:  Cancer Immunol Immunother       Date:  2009-01-31       Impact factor: 6.968

6.  Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines.

Authors:  F M Marincola; P Shamamian; T B Simonis; A Abati; J Hackett; T O'Dea; P Fetsch; J Yannelli; N P Restifo; J J Mulé
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1994-07

7.  Frequent transmission of cytotoxic-T-lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese population.

Authors:  Tae Furutsuki; Noriaki Hosoya; Ai Kawana-Tachikawa; Mariko Tomizawa; Takashi Odawara; Mieko Goto; Yoshihiro Kitamura; Tetsuya Nakamura; Anthony D Kelleher; David A Cooper; Aikichi Iwamoto
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

8.  Identification of HLA-A*24:02-Restricted CTL Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 and Analysis of Their Conservation Using the Mutation Database of SARS-CoV-2 Variants.

Authors:  Akira Takagi; Masanori Matsui
Journal:  Microbiol Spectr       Date:  2021-12-22

9.  Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein.

Authors:  I Couillin; B Culmann-Penciolelli; E Gomard; J Choppin; J P Levy; J G Guillet; S Saragosti
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.